PDCD1 and neoplasm: Unlike microsatellite-stable (MSS) CRCs, MSI-H not only had a much more active immune microenvironment with greater tumor-infiltrating lymphocytes (TIL), but also showed cancer-specific upregulation of inhibitory checkpoints including programmed cell death protein 1 (PD-1) and CTLA4 [5].